AIM - AIM ImmunoTech Inc.
0.0949
-0.023 -24.025%
Share volume: 2,305,517
Last Updated: 04-04-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$0.12
-0.02
-0.19%
View ratios
Fiscal Date | 12-31-2024 | |
---|---|---|
Fiscal Quarter | Q4 2024 | |
Report Date | 03-27-2025 | |
Cash flow financing | 1.037 M | |
Other financing cash flows | 0.000 | |
Cash flow | 786.000 K | |
Net income | -5.967 M | |
Depreciation | 9.000 K | |
Changes in inventories | 0.000 | |
Changes in receivables | 0.000 | |
Investing Cashflow | 3.704 M | |
Net Borrowings | 0.000 | |
Investing Activity Other | 0.000 | |
Dividends Paid | 0.000 | |
Exchange Rate Effect | 0.000 | |
Capital Expenditures | 0.000 | |
Cash Change | 786.000 K |